FilingSEC EDGAR6-K
Quantum BioPharma Signs Agreement with Thermo Fisher for Phase 2 Lucid-MS Clinical Trial
· SEC accepted
StagePhase 2
Filing content
Quantum BioPharma has entered into a study start-up agreement with Thermo Fisher Scientific's clinical research business to implement the Phase 2 clinical trial for its multiple sclerosis therapy, Lucid-MS.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…